Anixa Biosciences Inc. (ANIX)
NASDAQ: ANIX
· Real-Time Price · USD
3.27
-0.02 (-0.61%)
At close: Oct 03, 2025, 3:59 PM
3.35
2.39%
After-hours: Oct 03, 2025, 07:57 PM EDT
-0.61% (1D)
| Bid | 3.2 |
| Market Cap | 107.63M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -8.86M |
| EPS (ttm) | -0.34 |
| PE Ratio (ttm) | -9.62 |
| Forward PE | -9.68 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 3.43 |
| Volume | 65,274 |
| Avg. Volume (20D) | 107,085 |
| Open | 3.28 |
| Previous Close | 3.29 |
| Day's Range | 3.24 - 3.31 |
| 52-Week Range | 2.07 - 4.20 |
| Beta | 0.70 |
| Ex-Dividend Date | n/a |
About ANIX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ANIX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ANIX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+23.19%
Anixa Biosciences shares are trading higher after ...
Unlock content with
Pro Subscription
4 months ago
+12.45%
Anixa Biosciences shares are trading higher after the company announced it completed enrollment for its Phase 1 breast cancer vaccine clinical trial.
